Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Overview of This Study:

The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Primary Research:

Several stakeholders such as manufacturers, distributors, surgeons, and physicians from academic and government institutes were consulted for this report. The demand side of this market is characterized by the significant use of focused hemostats and sealants due to the favorable reimbursement scenario in European countries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Expected Revenue Growth:

The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

Geographical Growth Scenario:

UK to grow at the highest rate during the forecast period (2019–2024)

The European hemostats and sealants market is geographically segmented into Germany, UK, France, Italy, and Spain. While Germany dominated the market in 2019, the UK is expected to register the highest CAGR in the market during the forecast period. Germany holds the largest share amongst all the European countries, owing to its larger patient population and comparatively higher number of surgeries, which will require the usage of hemostats and sealants.

Key questions addressed in the report:

# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?

# What are the key drivers and restraints in the hemostats and sealants market?

# What are the key brands in the hemostats and sealants market?

# Which are the key countries in the hemostats and sealants market?

What are the most preferred brands amongst end users?

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

Key Market Players:

Some of the prominent players in the European hemostats and sealants market are B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe